Table 7.
IRAE | Gene Affected | Patients with CNV and IRAE | Deletions with IRAE | Duplications with IRAE | |||
---|---|---|---|---|---|---|---|
N | % | N | % | N | % | ||
IRAE |
TERT
LRRK2 IKZF1 SMAD3 JAK2 PRDM1 CTLA4 TSHR FAN1 SLCO1B1 PDCD1 IL1RN CD274 UNG |
31 24 27 25 28 24 10 16 29 39 19 13 14 22 |
69% 63% 68% 69% 65% 75% 71% 80% 73% 66% 68% 87% (p = 0.033) 78% 71% |
- 9 3 - 18 19 3 9 9 7 - 5 12 2 |
- 90% 75% - 78% 86% (p = 0.026) 75% 90% 82% 64% - 100% 80% 67% |
27 - 23 25 - - 6 - - 27 17 7 2 19 |
73% - 68% 69% - - 67% - - 66% 71% 78% 67% 70% |
Colitis |
TERT
IKZF1 SMAD3 FAN1 IL1RN |
10 11 8 8 4 |
22% 28% 22% 20% 27% |
2 - - 3 - |
29% - - 27% - |
- 11 8 - 3 |
- 32% 22% - 33% |
Hepatitis |
SH2B3
LRRK2 IKZF1 SMAD3 PRDM1 CTLA4 TSHR FAN1 SLCO1B1 IL1RN CD274 UNG |
5 8 7 8 5 3 5 8 13 4 4 5 |
19% 21% 18% 22% 16% 21% 25% 20% 22% (p = 0.010) 27% 22% 16% |
- 3 - - - - 2 - 2 - - - |
- 30% - - - - 20% - 18% - - - |
5 5 7 8 2 3 2 7 9 4 2 5 |
19% 19% 21% 22% 20% 33% 29% 28% 22% 44% 67% (p = 0.043) 19% |
Pancreatitis |
TERT
IKZF1 JAK2 FAN1 SLCO1B1 IL1RN UNG |
5 5 4 4 7 2 3 |
11% 13% 9% 10% 12% 13% 10% |
2 - - 2 - - - |
29% - - 18% - - - |
- 5 3 - 6 - - |
- 15% 15% - 15% - - |
Results analyzed in the main text are highlighted in bold.